Epigenetic reader domain inhibitor PLX51107, Purity ≥98%

Cat. No.: X24-05-ZQ478

Epigenetic reader domain inhibitor PLX51107, Purity ≥98%

Synonym: 1627929-55-8; PLX-51107; PLX 51107; Epigenetic reader domain inhibitor

  • CAS Number: 1627929-55-8
  • Compound CID: 90448953
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
PLX51107, soluble in DMSO and insoluble in ethanol and water, disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals.
Molecular Weight
438.487
Molecular Formula
C26H22N4O3
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 84 mg/mL (191.57 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
PLX51107 is employed in cancer research to study the inhibition of BET bromodomains and its therapeutic effects.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.